LAPSE:2021.0476
Published Article
LAPSE:2021.0476
Novel Hemocompatible Imine Compounds as Alternatives for Antimicrobial Therapy in Pharmaceutical Application
Mohammad A. Altamimi, Afzal Hussain, Sultan Alshehri, Syed Sarim Imam, Abdulmalik Alnami, Ahmed Bari
May 27, 2021
The aim of this study was to synthesize, characterize, and evaluate neoteric imine compounds for antimicrobial activity and hemocompatibility. Four compounds were synthesized using 3-thiophene carboxaldehyde, ethanol, amine, and acetic acid. The compounds were characterized using nuclear magnetic resonance (NMR) spectroscopy, Fourier transform infrared (FTIR) spectroscopy, differential scanning calorimetry (DSC), and powder X-ray diffraction (PXRD). A solubility study was conducted with various solvents and surfactants at 40 °C. An in vitro antimicrobial assay was performed against bacterial and fungal strains to determine the zone of inhibition and minimum inhibitory concentrations. Finally, an in vitro hemolysis study was conducted using rat erythrocytes. The structure of the compounds was confirmed by NMR, FTIR corroborated their functional group attributes, DSC determined their enthalpies of fusion and fusion temperatures, and PXRD confirmed their crystalline nature. These compounds were water-insoluble but soluble in chloroform, with a maximum solubility of ~80 mg/mL. The antimicrobial assay suggested that two of the products exerted potent activities against C. albicans and several bacterial strains. Finally, hemolysis analysis excluded the possibility of hemolysis at the assessed concentrations. In conclusion, two of the novel imine compounds showed promise as antimicrobial agents to control local and systemic microbial infections in a suitable dosage form.
Keywords
characterization, in vitro antimicrobial assay, in vitro hemolysis, local and systemic infection control, novel imine compounds
Subject
Suggested Citation
Altamimi MA, Hussain A, Alshehri S, Imam SS, Alnami A, Bari A. Novel Hemocompatible Imine Compounds as Alternatives for Antimicrobial Therapy in Pharmaceutical Application. (2021). LAPSE:2021.0476
Author Affiliations
Altamimi MA: Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia
Hussain A: Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia [ORCID]
Alshehri S: Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia; College of Pharmacy, Almaarefa University, Riyadh 11451, Saudi Arabia
Imam SS: Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia [ORCID]
Alnami A: Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia
Bari A: Central Laboratory, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia; Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia [ORCID]
Journal Name
Processes
Volume
8
Issue
11
Article Number
E1476
Year
2020
Publication Date
2020-11-17
Published Version
ISSN
2227-9717
Version Comments
Original Submission
Other Meta
PII: pr8111476, Publication Type: Journal Article
Record Map
Published Article

LAPSE:2021.0476
This Record
External Link

doi:10.3390/pr8111476
Publisher Version
Download
Files
[Download 1v1.pdf] (3.8 MB)
May 27, 2021
Main Article
License
CC BY 4.0
Meta
Record Statistics
Record Views
394
Version History
[v1] (Original Submission)
May 27, 2021
 
Verified by curator on
May 27, 2021
This Version Number
v1
Citations
Most Recent
This Version
URL Here
https://psecommunity.org/LAPSE:2021.0476
 
Original Submitter
Calvin Tsay
Links to Related Works
Directly Related to This Work
Publisher Version